Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03920631
Title Microtransplantation and Checkpoint Blockade Immunotherapy for Relapsed or Refractory B Cell Lymphomas (MicroBLITZ)
Recruitment Withdrawn
Gender both
Phase Phase I
Variant Requirements No
Sponsors Duke University
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Duke University Durham North Carolina 27705 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field